I know that it will probably never happen, but I so wish that it would, and thinking about it gives me a warm feeling in the Nethers.
Anticipating a ruling from the bench of Federal Circuit Judge Matthew Kacsmaryk striking down the FDA’s approval of Mifepristone, I propose that the FDA, with the support of the DOJ, withdraw its approval of PDE-5 inhibitors. You know these medicines as Viagra, Levitra, and Cialis among others. Such a ruling from the FDA would make it a crime to dispense these drugs.
The FDA could argue that it didn’t adequately study the health risks that would accrue to women who experienced unintended pregnancy at the penises of partners who used these medicines. The DOJ could come up with other arguments, I think.
The bottom line here is that if the FDA’s approval of Mifepristone proceeded without adequate study of its safety, then the approval of ED drugs did so as well. I wonder how long it would take for this case to reach the SCOTUS after ED drug approval was withdrawn. Hmnm.
For the record, the first PDE-5 inhibitor medication, Rovatio aka Viagra, was actually developed for the treatment of Primary Pulmonary Hypertension (PPH) – a particularly cruel disease that can occur at any age causing right-sided heart failure, disability and death. Just like Mifepristone which is used to manage miscarriages (spontaneous abortions) which occur in between 15-30% of all pregnancies, withdrawing the approval PDE-5 would harm people who are taking it for reasons other than a limp pecker – what we might call DTS or Donald Trump Syndrome.
As I am confident that judge Kacsmaryk would say of denying Mefipristone to women experiencing a miscarriage, the suffering of individuals taking PDE-5 medicines for PPH would be “unfortunate.”